The African Institute of Biomedical Science and Technology, AiBST, is a research and education institute with a mission to discover, develop and deploy innovative healthcare solutions for Africa. Combining postgraduate education and biomedical R&D is enabling AiBST to operate in an environment which still requires capacity and capability building with respect to skilled manpower and research infrastructure,whilst conducting translational research to deliver on medical products and services that address Africa’s healthcare challenges.

AiBST was founded in 2002 by Professor Collen Masimirembwa. Its initial activities were the organisation of courses on the science and technology of drug discovery and development. The first course was in Cape Town (South Africa) in 2002 and focused on ADMET for drug discovery. The second one was in Nairobi (Kenya) in 2003 focusing on Pharmacogenetics of Drug Metabolism.